Patent · US Expired

Antibodies to human IL-17F and other CTLA-8-related proteins

US6902735B1 · kind B1 · utility

23Cited by

5References

30Claims

0Family size

Assignee

Genetics Institute, LLC · US

Inventors

Kenneth Jacobs · Newton, US
Kerry Kelleher · Marlborough, US
McKeough Carlin · Cambridge, US
Samuel Goldman · Acton, US
Debra Pittman · Windham, US
Sha Mi · Belmont, US
Steven Neben · Acton, US
Joanne Giannotti · Acton, US
Margaret M. Golden-Fleet · Medford, US

Key dates

Filing date	Mar 19, 2002
Grant date	Jun 7, 2005
Priority date	—
Expiry date	Mar 19, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polynucleotides encoding human CTLA-8 (now known as IL-17F) and related proteins are disclosed. Human CTLA-8 and related proteins, including anti-human IL-17F antibodies, and methods for their production are also disclosed. Methods of treatment using human CTLA-8 proteins, rat CTLA-8 proteins and herpes CTLA-8 proteins are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.